FDA grants speedy approval to Eli Lilly’s weight-loss GLP-1 pill Foundayo for obesity

Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The U.S. Food and Drug Administration has granted accelerated approval to orforgliprone, a GLP-1 drug that works like widely used injectable drugs to mimic the natural hormone that controls appetite and feelings of … Read more

MGB researchers unveil genetic risk calculator for obesity, T2D

health Researchers say the new tool could help predict health risks associated with obesity early and reshape prevention strategies. A researcher measures a subject’s waist during an obesity prevention study in Chicago. AFP Photo/M. Spencer Green, file Researchers from Mass General Brigham have developed a new genetic risk calculator designed to predict not only who … Read more